TOA

TOA Biopharma is a Japan-based pharmaceutical and probiotics company focused on the development, manufacture, and commercialization of probiotic products for human and animal health. The company traces its business to probiotic product development and markets the BIO-THREE franchise, including prescription and consumer-oriented products intended to regulate intestinal function and improve symptoms associated with dysbiosis. In addition to prescription drugs, TOA Biopharma operates in quasi-drugs, healthcare products, and veterinary and feed-related products, and it conducts its own research, manufacturing, and quality control. The company appears to be an operating commercial-stage specialty health company rather than a venture-stage therapeutic biotech.